Local Gene Delivery and Methods to Control Immune Responses in Muscles of Normal and Dystrophic Dogs
Adeno-associated viral vector (AAV)-mediated gene transfer represents a promising gene replacement strategy for treating Duchenne muscular dystrophy (DMD). However, recent studies demonstrated cellular immunity specific to AAV capsid proteins in animal models, which resulted in liver toxicity and elimination of transgene expression in a human trial of hemophilia B. We have recently developed immunosuppressive strategies to prevent such immunity for successful long-term transgene expression in dog muscle. Here, we describe in detail the immunosuppressive regimens employed in both normal and DMD dogs and provide methods for evaluating the efficiency of the regimens following intramuscular injection of AAV in dogs.
- Submission of Nucleotide Sequence Data to EMBL/GenBank/DDBJ
- C. elegans Sirtuins
- Use of RNAi in C. elegans
- Probing Telomeric G-Quadruplex DNA Structures in Cells with In Vitro Generated Single-Chain Antibody Fragments
- A Highly Efficient Gene Delivery System Derived from Feline Immunodeficiency Virus (FIV)
- Cell Biological Approaches to Investigate Polyglutamine-Expanded AR Metabolism
- Molecular Biology and Medicine: Ethical Implications
- A Hit Map-Based Statistical Method to Predict Best Ligands for Orphan Olfactory Receptors: Natural Key Odorants Versus Lock Pick
- Perturbing A-to-I RNA Editing Using Genetics and Homologous Recombination
- Design and Fabrication of Spotted Long Oligonucleotide Microarrays for Gene Expression Analysis